TD Asset Management
AMAM

TD Asset Management’s Ambrx Biopharma Inc AMAM Stock Holding History

TD Asset Management’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-140,256
Closed -$2M – 1458
2023
Q4 		$2M Buy
140,256
+29,800
+27% +$339K ﹤0.01% 1009
2023
Q3 		$1.27M Buy
110,456
+46,728
+73% +$636K ﹤0.01% 1084
2023
Q2 		$1.05M Buy
63,728
+49,828
+358% +$627K ﹤0.01% 1123
2023
Q1 		$124K Buy
+13,900
New +$69.9K ﹤0.01% 1397

TD Asset Management's AMAM Position: Q1 2024 in Review

TD Asset Management sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 140,256 shares — an estimated $2M sold.

TD Asset Management first reported a position in AMAM in Q1 2023 and held it in 4 quarters. The position peaked at $2M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

  • TD Asset Management reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • TD Asset Management sold 140,256 Ambrx Biopharma Inc shares in Q1 2024, an estimated $2M.
  • TD Asset Management first reported a position in Ambrx Biopharma Inc in Q1 2023 and held it in 4 quarters.
  • TD Asset Management's Ambrx Biopharma Inc position peaked at $2M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on TD Asset Management's 13F filing for Q1 2024, filed 8 May 2024.